Literature DB >> 3048273

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.

G A McCain1, D A Bell, F M Mai, P D Halliday.   

Abstract

Forty-two patients with primary fibromyalgia were randomized into a 20-week program consisting of either cardiovascular fitness (CVR) training or simple flexibility exercises (FLEX) that did not lead to enhanced cardiovascular fitness. Patients were supervised by the same medical fitness instructors. Patients in neither group had contact with members of the other group, and were blinded as to the exercise taught to the alternative group. Groups met for 60 minutes 3 times each week. The compliance rate was 90%. Thirty-eight patients completed the study (18 with CVR training and 20 with FLEX). Blind assessments (standardized in preliminary trials to achieve acceptable inter-rater agreement) were performed by the same 2 examiners. After 20 weeks, patients receiving CVR training showed significantly improved cardiovascular fitness scores compared with those receiving FLEX training (t[35] = -4.22, P less than 0.003). Logistic regression analysis showed clinically and statistically significant improvements in pain threshold scores, which were measured directly over fibrositic tender points, in patients undergoing CVR (t[35] = 2.21, P less than 0.04). There was also a trend toward improvement in pain scores (visual analog scale) in the CVR group, but this did not reach statistical significance. There was no improvement in the percentage of body area affected by fibrositic symptoms or the number of nights per week or hours per night of disturbed sleep (self-report inventories). However, compared with the FLEX group, the CVR-trained patients improved significantly in both patient and physician global assessment scores.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3048273     DOI: 10.1002/art.1780310908

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  53 in total

Review 1.  The treatment of fibromyalgia: a review of clinical trials.

Authors:  L J Crofford; B E Appleton
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

2.  Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input.

Authors:  Roland Staud; Michael E Robinson; Elizabeth E Weyl; Donald D Price
Journal:  J Pain       Date:  2010-05-07       Impact factor: 5.820

Review 3.  [Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  A Winkelmann; W Häuser; E Friedel; M Moog-Egan; D Seeger; M Settan; T Weiss; M Schiltenwolf
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 4.  Treatment of myofascial pain syndrome.

Authors:  Chang-Zern Hong
Journal:  Curr Pain Headache Rep       Date:  2006-10

5.  Managing future Gulf War Syndromes: international lessons and new models of care.

Authors:  Charles C Engel; Kenneth C Hyams; Ken Scott
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

6.  Is balance exercise training as effective as aerobic exercise training in fibromyalgia syndrome?

Authors:  Neslihan Duruturk; Emine Handan Tuzun; Belde Culhaoglu
Journal:  Rheumatol Int       Date:  2014-10-22       Impact factor: 2.631

7.  [Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Häuser; E Felde; C Flügge; R Häfner; M Settan; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

8.  Fibromyalgia: Does it Exist?

Authors:  O G Zadorozny
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

Review 9.  A realistic approach to managing patients with fibromyalgia.

Authors:  Geoffrey O Littlejohn; Janine Walker
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 10.  Pharmaceutical treatment options for fibromyalgia.

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.